Clinical Outcome Assessment Instruments in Schizophrenia: A Scoping Literature Review with a Focus on the Potential of Patient-reported Outcomes
by Leslie Citrome, MD, MPH; Marko A. Mychaskiw, BSRPh, MS, [...]
Letter to the Editor: Open Bite Malocclusion Following Aripiprazole Treatment in Children and Adolescents
Funding/financial disclosures. The author has no conflicts of interest relevant [...]
Xanomeline and Trospium: A Potential Fixed Drug Combination (FDC) for Schizophrenia—A Brief Review of Current Data
by Alok Singh, MD Dr. Singh is with All India [...]
A Cannabinoid Hypothesis of Schizophrenia: Pathways to Psychosis
by Rachel Little, MA, and Dale D’Mello, MD Ms. Little [...]
Anatomical Association Between Schizophrenia and Cerebellum
by Rajashekar Reddy Yeruva, MD; Yafei Shang, MD; Ben Schoenbachler, [...]
Capturing Clinical Symptoms with Ecological Momentary Assessment: Convergence of Momentary Reports of Psychotic and Mood Symptoms with Diagnoses and Standard Clinical Assessments
by Philip D. Harvey, PhD; Michelle L. Miller, MS; Raeanne [...]
Role of Norepinephrine in Schizophrenia: An Old-fashioned but New Story from Emergency Medicine
Dear Editor: A number of hypotheses have been put forth [...]
The Role of Serum Lithium Concentration on Pill Burden in Psychiatric Populations
by Charisse Chehovich, PharmD; Tammie Lee Demler, BS, PharmD, MBA, [...]
Do Patterns of Instability or Severity of Psychopathology During Screening Predict Relapse in Schizophrenic Outpatient Subjects with Moderate to Severe Negative Symptoms Assigned to Placebo?
by David G. Daniel, MD; Alan Kott, MD; Jay Saoud, [...]
The Effects of Paliperidone Palmitate 1 Month on the Employment Status and Social Functioning of Patients with Schizophrenia
by Takashi Ohnishi, MD, PhD; Hisanori Kobayashi, PhD; Toshio Yamaoka; [...]